As the COVID virus continues to evolve, experts in respiratory diseases recommend that everyone ages 6 months and older ...
Analyst Eric Joseph of J.P. Morgan maintained a Sell rating on Novavax (NVAX – Research Report), retaining the price target of $9.00.
The European Commission authorized Novavax's updated COVID-19 vaccine targeting the JN.1 strain of coronavirus in the region, ...
The Novavax vaccine that will be trialled at the Mater in Brisbane is a protein-based vaccine that contains part of the ...